Log in to save to my catalogue

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bd28bd0bf05246bbaccb1e4e99e36462

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor

About this item

Full title

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor

Publisher

London: Nature Publishing Group UK

Journal title

NPJ breast cancer, 2022-04, Vol.8 (1), p.44-44, Article 44

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Malignant phyllodes tumors (PT) are rare aggressive fibroepithelial neoplasms with high metastatic potential and lack effective therapy. We established a patient-derived xenograft (PDX) and cell line model (designated MPT-S1) of malignant PT which demonstrated clinical response to pazopanib. Whole exome sequencing identified somatic mutations in

Alternative Titles

Full title

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_bd28bd0bf05246bbaccb1e4e99e36462

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bd28bd0bf05246bbaccb1e4e99e36462

Other Identifiers

ISSN

2374-4677

E-ISSN

2374-4677

DOI

10.1038/s41523-022-00413-1

How to access this item